Skip to main content
. 2022 Jan 6;22:26. doi: 10.1186/s12890-021-01772-4

Fig. 3.

Fig. 3

Distribution of physician survey taker assessment of the risk of malignancy. A Percepta GSC very high risk up-classification resulted in a signficantly higher mean assessment of ROM in the independent cohort with Percepta GSC compared to the independent cohort without a GSC result (left). Providing a very high risk result significantly increased the mean assessment of ROM in the pre–post cohort (right). In all three cohorts, physicians frequently assessed ROM to be < 60%. ROM risk of malignancy